drugset / Trial / NCT05154968

A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants

NCT05154968

Phase 1 Completed 44 enrolled Eli Lilly and Company
RandomizedCrossoverSingle-blindTreatment

Summary

The main purpose of the study is to assess the injection site pain intensity of two formulations using prefilled autoinjector device in healthy participants.

Timeline

Start
2021-11-24
Primary completion
2021-12-14
Completion
2021-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Citrate buffer Unknown Subcutaneous
Subject Mannitol Diagnostic / imaging agent Subcutaneous
Subject sodium chloride Unknown Subcutaneous

Indications

No indication recorded.